(Reuters) -The Centers for Medicare & Medicaid Services said on Friday that it did not move forward with a proposal put forth ...
Trump’s tariffs on EU goods could slash exports by at least €85 billion, hitting autos and pharmaceuticals hardest. Germany, ...
Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...
Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.
Novo Nordisk has licensed an oral obesity drug that works via an uncommon mechanism and may help patients maintain their ...
Reduced sales could also hurt Novo Nordisk’s stock value and put pressure on Denmark’s economy, which relies heavily on ...
Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...
Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
Americans pay far more for GLP-1 drugs than citizens in other wealthy nations. If Dr. Marty Makary, the new FDA commissioner, ...
This massive loss of poultry, especially egg-laying hens, has led to a supply shortage, which continues to drive prices higher. Why did Poland, Finland, and Denmark reject egg exports to the U.S.?
Roberto Martinez's side dominated possession in the Danish capital but had fewer shots (23-9) and shots on target (9-2) than the hosts, which proved key in the eventual scheme of things.
Portugal midfielder Bruno Fernandes has opened up on his side's 1-0 loss against Denmark in the first leg ... out when he's the only one pulling his weight in this team." "There are others doing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results